Connection

John Colwell to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications John Colwell has written about Diabetes Mellitus, Type 2.
John Colwell
Connection Strength
1.523
Diabetes Mellitus, Type 2
  1. Does aspirin use reduce cardiovascular risk in diabetes? Nat Rev Endocrinol. 2009 Apr; 5(4):188-90.
    View in: PubMed
    Score: 0.168
  2. Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 1998 Apr; 21(4):510-5.
    View in: PubMed
    Score: 0.078
  3. Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism. 1997 Dec; 46(12 Suppl 1):1-4.
    View in: PubMed
    Score: 0.077
  4. Controlling type 2 diabetes: are the benefits worth the costs? JAMA. 1997 Nov 26; 278(20):1700.
    View in: PubMed
    Score: 0.076
  5. Pharmacological strategies to prevent macrovascular disease in NIDDM. Diabetes. 1997 Sep; 46 Suppl 2:S131-4.
    View in: PubMed
    Score: 0.075
  6. Aspirin therapy in diabetes mellitus. Diabetologia. 1997 Jul; 40(7):867.
    View in: PubMed
    Score: 0.074
  7. Should we use intensive insulin therapy after oral agent failure in type II diabetes? Diabetes Care. 1996 Aug; 19(8):896-8.
    View in: PubMed
    Score: 0.070
  8. Intensive insulin therapy in type II diabetes: rationale and collaborative clinical trial results. Diabetes. 1996 Jul; 45 Suppl 3:S87-90.
    View in: PubMed
    Score: 0.069
  9. The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM. Ann Intern Med. 1996 Jan 01; 124(1 Pt 2):131-5.
    View in: PubMed
    Score: 0.067
  10. Forum Two: Unanswered research questions about metabolic control in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996 Jan 01; 124(1 Pt 2):178-9.
    View in: PubMed
    Score: 0.067
  11. Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes. Diabetes Care. 1995 Aug; 18(8):1150-5.
    View in: PubMed
    Score: 0.065
  12. Platelet plasminogen activator inhibitor 1 in patients with type II diabetes. Diabetes Care. 1994 Aug; 17(8):818-23.
    View in: PubMed
    Score: 0.061
  13. Is it time to introduce metformin in the U.S.? Diabetes Care. 1993 Apr; 16(4):653-5.
    View in: PubMed
    Score: 0.055
  14. Vascular thrombosis in type II diabetes mellitus. Diabetes. 1993 Jan; 42(1):8-11.
    View in: PubMed
    Score: 0.054
  15. Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Hyperlipidemia in Diabetes Investigators. Diabetes Care. 1993 Jan; 16(1):37-44.
    View in: PubMed
    Score: 0.054
  16. Oral treatment of diabetes mellitus: the contribution of gliclazide. Am J Med. 1991 Jun 24; 90(6A):1S-2S.
    View in: PubMed
    Score: 0.049
  17. Aspirin for primary prevention of cardiovascular events in people with diabetes. J Am Coll Cardiol. 2010 Jun 22; 55(25):2878-86.
    View in: PubMed
    Score: 0.046
  18. Hemostatic alterations with exercise conditioning in NIDDM. Diabetes Care. 1990 Feb; 13(2):87-92.
    View in: PubMed
    Score: 0.044
  19. V.A. Cooperative Study of antiplatelet agents in diabetic patients after amputation for gangrene: unobserved, sudden, and unexpected deaths. J Diabet Complications. 1989 Oct-Dec; 3(4):191-7.
    View in: PubMed
    Score: 0.043
  20. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care. 1986 Mar-Apr; 9(2):140-8.
    View in: PubMed
    Score: 0.034
  21. Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators. Diabetes Care. 2000 Oct; 23(10):1478-85.
    View in: PubMed
    Score: 0.023
  22. Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care. 2000 Sep; 23(9):1316-20.
    View in: PubMed
    Score: 0.023
  23. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications. 1999 Sep-Dec; 13(5-6):307-13.
    View in: PubMed
    Score: 0.022
  24. Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus. Arch Intern Med. 1998 Dec 7-21; 158(22):2485-90.
    View in: PubMed
    Score: 0.021
  25. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM). Diabetes Care. 1998 Apr; 21(4):574-9.
    View in: PubMed
    Score: 0.020
  26. A critical issue. Intensive insulin treatment and macrovascular disease. Diabetes Care. 1998 Apr; 21(4):669-71.
    View in: PubMed
    Score: 0.020
  27. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med. 1997 Jan 27; 157(2):181-8.
    View in: PubMed
    Score: 0.018
  28. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study. Diabetes Care. 1996 Dec; 19(12):1375-81.
    View in: PubMed
    Score: 0.018
  29. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995 Aug; 18(8):1113-23.
    View in: PubMed
    Score: 0.016
  30. Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM) Diabetes Care. 1992 Nov; 15(11):1560-71.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.